Summary of NICE guidance for Psoriasis

Karoline Brennan, Senior Medicines Information Pharmacist, North West Medicines Information CentreSource North West Medicines Information CentrePublished

Since this edition of NICE Bites was published, NICE revised the guideline to include new MHRA safety advice and updated licensing information, and to link to other NICE guidance and technology appraisals and some non-NICE guidelines.

NICE has also produced a COVID-19 rapid guideline on dermatological conditions treated with drugs affecting the immune response.

Please go to NICE for details and to check for any further updates to this guideline.

NICE Bites is a monthly bulletin which summarises key prescribing points from NICE guidance. NICE Bites No 49, Jan/Feb 2013 includes one topic: Psoriasis (NICE CG153). Sections covered include: assessment and referral, active topical treatments (corticosteroids, vitamin D and vitamin D analogues, coal tar, dithranol), phototherapy, systemic non-biological therapy (methotrexate, ciclosporin), systemic biological treatments and monitoring.

(This website entry checked November 2020)